1 |
Jia SN, Han YB, Yang R, Yang ZC. Chemokines in colon cancer progression. Semin Cancer Biol 2022;86:400-7. [PMID: 35183412 DOI: 10.1016/j.semcancer.2022.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
|
2 |
Yang F, Hu T, Liu J, Yu X, Ma L. Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114920] [Reference Citation Analysis]
|
3 |
Ahmad A. Guest Edited Collection: Epigenetics within the tumor microenvironment. Sci Rep 2022;12:15089. [PMID: 36064963 DOI: 10.1038/s41598-022-19042-6] [Reference Citation Analysis]
|
4 |
Xiong K, Qi M, Stoeger T, Zhang J, Chen S. The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma. Front Immunol 2022;13:1000927. [DOI: 10.3389/fimmu.2022.1000927] [Reference Citation Analysis]
|
5 |
Ahmad A. Exosomes in Cancer Diagnosis and Therapy. IJMS 2022;23:9930. [DOI: 10.3390/ijms23179930] [Reference Citation Analysis]
|
6 |
Guo W, Liu G, Guan J, Chen Y, Zhao Y, Wang K, Bai O. Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment. Front Oncol 2022;12:977266. [DOI: 10.3389/fonc.2022.977266] [Reference Citation Analysis]
|
7 |
Farooqi AA, Kapanova G, Kussainov AZ, Datkhayeva Z, Raganina K, Sadykov BN. Regulation of RASSF by non-coding RNAs in different cancers. Non-coding RNA Research 2022. [DOI: 10.1016/j.ncrna.2022.04.001] [Reference Citation Analysis]
|
8 |
Naqvi AR, Sarwat M. MicroRNAs and immunity. Semin Cell Dev Biol 2021:S1084-9521(21)00270-6. [PMID: 34736822 DOI: 10.1016/j.semcdb.2021.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|